ebomi
Colour theme
Sign in
Insider · CIK 0001317493

14159 capital (Gp), LLC

CIK 0001317493 Name as filed on the most recent filing

Filed as 14159 capital (Gp), LLC (180)· 14159 Capital (Gp, LLC (6)

642 transaction lines · from 186 filings · filed 2005-02-14 to 2012-03-14 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-28 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-28 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2007-11-12 P, Open-market purchase Incyte CorpINCY 5,574, acquired Open Form 4 filing 0001144204-07-060662
2007-11-12 P, Open-market purchase Incyte CorpINCY 2,822, acquired Open Form 4 filing 0001144204-07-060662
2007-11-09 P, Open-market purchase Viropharma IncVPHM 47,967, acquired Open Form 4 filing 0001144204-07-059935
2007-11-09 P, Open-market purchase Incyte CorpINCY 2 lines 49,319, acquired Open Form 4 filing 0001144204-07-060662
2007-11-08 S, Open-market sale Idera Pharmaceuticals, Inc.IDP 4,046, disposed Open Form 4 filing 0001144204-07-059382
2007-11-08 P, Open-market purchase Viropharma IncVPHM 81,967, acquired Open Form 4 filing 0001144204-07-059935
2007-11-07 S, Open-market sale Idera Pharmaceuticals, Inc.IDP 18,974, disposed Open Form 4 filing 0001144204-07-059382
2007-11-07 P, Open-market purchase Viropharma IncVPHM 64,167, acquired Open Form 4 filing 0001144204-07-059935
2007-11-06 S, Open-market sale Idera Pharmaceuticals, Inc.IDP 22,993, disposed Open Form 4 filing 0001144204-07-059382
2007-11-05 S, Open-market sale Idera Pharmaceuticals, Inc.IDP 2,905, disposed Open Form 4 filing 0001144204-07-058239
2007-11-02 S, Open-market sale Idera Pharmaceuticals, Inc.IDP 7,435, disposed Open Form 4 filing 0001144204-07-058239
2007-11-01 S, Open-market sale Idera Pharmaceuticals, Inc.IDP 5,750, disposed Open Form 4 filing 0001144204-07-058239
2007-10-31 S, Open-market sale Idera Pharmaceuticals, Inc.IDP 8,783, disposed Open Form 4 filing 0001144204-07-057584
2007-10-31 S, Open-market sale Idera Pharmaceuticals, Inc.IDP 8,783, disposed Open Form 4 filing 0001144204-07-057389
2007-10-30 S, Open-market sale Idera Pharmaceuticals, Inc.IDP 11,980, disposed Open Form 4 filing 0001144204-07-057584
2007-10-30 S, Open-market sale Idera Pharmaceuticals, Inc.IDP 11,980, disposed Open Form 4 filing 0001144204-07-057389
2007-10-29 S, Open-market sale Idera Pharmaceuticals, Inc.IDP 13,290, disposed Open Form 4 filing 0001144204-07-057584
2007-10-29 S, Open-market sale Idera Pharmaceuticals, Inc.IDP 13,290, disposed Open Form 4 filing 0001144204-07-057389
2007-08-03 P, Open-market purchase Incyte CorpINCY 25,895, acquired Open Form 4 filing 0001144204-07-040231
2007-08-02 P, Open-market purchase Incyte CorpINCY 7,305, acquired Open Form 4 filing 0001144204-07-040231
2007-08-01 P, Open-market purchase Incyte CorpINCY 37,275, acquired Open Form 4 filing 0001144204-07-040231
2007-06-21 S, Open-market sale Allos Therapeutics IncALTH 11,452, disposed Open Form 4 filing 0001144204-07-033025
2007-06-20 S, Open-market sale Idera Pharmaceuticals, Inc.IDP 863, disposed Open Form 4 filing 0001144204-07-033209
2007-06-20 P, Open-market purchase Idera Pharmaceuticals, Inc.IDP 854, acquired Open Form 4 filing 0001144204-07-033209
2007-06-19 S, Open-market sale Allos Therapeutics IncALTH 3 lines 143,750, disposed Open Form 4 filing 0001144204-07-033025
2007-05-30 P, Open-market purchase Genomic Health IncGHDX 2 lines 6,873, acquired Open Form 4 filing 0001144204-07-029397
2007-05-29 P, Open-market purchase Genomic Health IncGHDX 47,110, acquired Open Form 4 filing 0001144204-07-029397
2007-05-25 P, Open-market purchase Genomic Health IncGHDX 57,082, acquired Open Form 4 filing 0001144204-07-029397
2007-05-24 P, Open-market purchase Genomic Health IncGHDX 2 lines 33,769, acquired Open Form 4 filing 0001144204-07-028572
2007-05-23 P, Open-market purchase Genomic Health IncGHDX 36,264, acquired Open Form 4 filing 0001144204-07-028572
2007-05-22 P, Open-market purchase Genomic Health IncGHDX 199,767, acquired Open Form 4 filing 0001144204-07-028572
2007-05-21 P, Open-market purchase Genomic Health IncGHDX 348,611, acquired Open Form 4 filing 0001144204-07-027933
2007-05-21 P, Open-market purchase Genomic Health IncGHDX 16, acquired Open Form 4 filing 0001144204-07-027928
2007-04-17 S, Open-market sale Viropharma IncVPHM 3 lines 53,677, disposed Open Form 4 filing 0001144204-07-019278
2007-04-16 S, Open-market sale Viropharma IncVPHM 2 lines 25,793, disposed Open Form 4 filing 0001144204-07-019278
2007-04-13 S, Open-market sale Viropharma IncVPHM 2 lines 147,728, disposed Open Form 4 filing 0001144204-07-019278
2007-03-09 P, Open-market purchase Genomic Health IncGHDX 2 lines 98,260, acquired Open Form 4 filing 0001144204-07-012455
2007-03-02 P, Open-market purchase Genomic Health IncGHDX 4,344, acquired Open Form 4 filing 0001144204-07-011204
2007-03-01 P, Open-market purchase Genomic Health IncGHDX 20,443, acquired Open Form 4 filing 0001144204-07-011204
2007-03-01 P, Open-market purchase Genomic Health IncGHDX 5,953, acquired Open Form 4 filing 0001144204-07-011204

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. 14159 capital (GP), LLC, insider transactions. Retrieved 2026-08-28 from https://ebomi.com/insider/0001317493

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.